Fort Washington Investment Advisors’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
Fort Washington Investment Advisors's ANGO Position: Q4 2019 in Review
Fort Washington Investment Advisors sold out of AngioDynamics (ANGO) in Q4 2019, closing a stake of 681,319 shares — an estimated $12.6M sold.
Fort Washington Investment Advisors first reported a position in ANGO in Q4 2017 and held it in 8 quarters. The position peaked at $17.9M in Q2 2018. 157 funds tracked by Wall St. Rank hold ANGO as of Q4 2019.
- Fort Washington Investment Advisors reported no remaining AngioDynamics position as of Q4 2019 after selling out during the quarter.
- Fort Washington Investment Advisors sold 681,319 AngioDynamics shares in Q4 2019, an estimated $12.6M.
- Fort Washington Investment Advisors first reported a position in AngioDynamics in Q4 2017 and held it in 8 quarters.
- Fort Washington Investment Advisors's AngioDynamics position peaked at $17.9M in Q2 2018.
- 157 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2019.
Based on Fort Washington Investment Advisors's 13F filing for Q4 2019, filed 3 Feb 2020.